Eton Pharmaceuticals (ETON) Inventory (2019 - 2025)

Eton Pharmaceuticals (ETON) has 7 years of Inventory data on file, last reported at $15.4 million in Q4 2025.

• For the quarter ending Q4 2025, Inventory rose 1.23% year-over-year to $15.4 million; the trailing twelve-month figure through Dec 2025 stood at $15.4 million (up 1.23% YoY), and the FY2025 full-year result was $15.4 million, up 1.23% from the prior year.
• Inventory slipped to $15.4 million in Q4 2025, from $16.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $23.8 million in Q2 2025 to a low of $334000.0 in Q3 2021.
• A 5-year average of $5.0 million and a median of $1.1 million in 2021 frame the typical range for Inventory.
• Across the five-year window, Inventory tumbled 80.34% in 2021 and surged 1572.01% in 2024, its largest moves.
• Tracing ETON's Inventory over 5 years: stood at $550000.0 in 2021, then advanced by 1.27% to $557000.0 in 2022, then surged by 63.55% to $911000.0 in 2023, then surged by 1572.01% to $15.2 million in 2024, then increased by 1.23% to $15.4 million in 2025.
• Business Quant data shows ETON's Inventory at $15.4 million in Q4 2025, $16.9 million in Q3 2025, and $23.8 million in Q2 2025.